4//SEC Filing
Wegman Toby 4
Accession 0001062993-19-002375
CIK 0000875622other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 3:46 PM ET
Size
6.8 KB
Accession
0001062993-19-002375
Insider Transaction Report
Form 4
Wegman Toby
Director10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2019-05-21$64.67/sh−100$6,467→ 945,073 total(indirect: See footnote) - Sale
Common Stock, $0.001 par value
2019-05-21$64.05/sh−5,400$345,887→ 945,173 total(indirect: See footnote)
Footnotes (2)
- [F1]The selling price of $64.0531 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $63.535 to $64.44. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]These shares are held in trust on behalf of the reporting person. The reporting person is the trustee of the trust. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001405128
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 3:46 PM ET
- Size
- 6.8 KB